The Technical Analyst
Danimer Scientific, Inc. [DNMR]
Exchange: NYSE Sector: Basic Materials Industry: Specialty Chemicals
Danimer Scientific, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
1.27% $0.800
America/New_York / 9 mai 2024 @ 10:42
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 91.37 mill |
| EPS: | -1.520 |
| P/E: | -0.530 |
| Earnings Date: | May 08, 2024 |
| SharesOutstanding: | 114.24 mill |
| Avg Daily Volume: | 0.929 mill |
| RATING 2024-05-08 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Strong Buy | |
| P/E: | Neutral | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.530 | sector: PE 54.44 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.02x |
| Company: PE -0.530 | industry: PE 33.63 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.689 - 0.911 ( +/- 13.88%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-04-15 | Altice Richard N. | Buy | 8 242 | Restricted Stock Units |
| 2024-04-15 | Altice Richard N. | Sell | 0 | No securities are beneficially owned |
| 2024-04-03 | Van Trump Phillip D | Buy | 263 410 | Stock Appreciation Rights |
| 2024-04-03 | Van Trump Phillip D | Buy | 151 585 | Performance Stock Award |
| 2024-04-03 | Tuten Scott | Buy | 263 410 | Stock Appreciation Rights |
| INSIDER POWER |
|---|
| 87.79 |
| Last 95 transactions |
| Buy: 9 095 577 | Sell: 872 586 |
Forecast:
12:23 - $0.794
Live Trading Signals (every 1 min)
Forecast
1: 10:53 - $0.801
Forecast 2: 11:43 - $0.794
Forecast 3: 12:23 - $0.794
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.800 (1.27% ) |
| Volume | 0.130 mill |
| Avg. Vol. | 0.929 mill |
| % of Avg. Vol | 14.03 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For DNMR
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
DNMR
Danimer Scientific, Inc., a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company offers its products for biopolymers, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry. Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia.
Latest Press Releases
2024-05-06 16:30:00 - Press Release
Danimer Scientific Reveals New Branding And New Applications Based On Pha During Npe 2024
Bainbridge, ga.--(business wire)---- $dnmr--danimer scientific, inc. (nyse: dnmr) (“danimer” or the “company”), a leading next-generation bioplastics company focused on the development and production of pha biopolymers, is unveiling new commercial applications and branding during npe 2024, north america's largest plastics tradeshow, taking place this week in orlando, fl. a more perfect polymer™ takes center stage at npe 2024. danimer's signature pha, nodax®, represents a more perfect polymer revolution.
2024-05-02 16:45:00 - Press Release
Danimer Scientific Announces Proposed Pro-rata Distribution Of Warrants To Purchase Common Stock
Bainbridge, ga.--(business wire)--danimer scientific, inc. (nyse: dnmr) (“company” or “danimer scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced a proposed pro-rata dividend distribution of warrants (“dividend warrants”) to holders of the company's class a common stock, par value $0.0001 per share (“common stock”) as of may 13, 2024 (“record date”). subject to the company's stockholders approving a p.
2024-05-01 08:30:00 - Press Release
Danimer Scientific Announces Release Date For First Quarter 2024 Results
Bainbridge, ga.--(business wire)--danimer scientific, inc. (nyse: dnmr) (“danimer” or the “company”), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the company will release its first quarter 2024 financial results after the market closes on tuesday may 7, 2024. a webcast and conference call will be held that same day at 4:30 p.m. eastern time to review the company's first quarter results, discuss recent.
2024-04-22 08:30:00 - Press Release
Danimer Scientific Announces $20 Million Asset-based Revolving Credit Facility
Bainbridge, ga.--(business wire)--danimer scientific, inc. (nyse: dnmr) (the “company” or “danimer scientific”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today, that on april 19, 2024, it entered into an asset-based revolving credit and security agreement with mountain ridge capital secured primarily by the company's accounts receivable and inventory. the credit and security agreement provides for borrowings un.
2024-03-28 16:01:00 - Press Release
Danimer Scientific Announces Fourth Quarter And Full Year 2023 Results
Bainbridge, ga.--(business wire)--danimer scientific, inc. (nyse: dnmr) (“danimer” or the “company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its fourth quarter and full year, ended december 31, 2023. stephen e. croskrey, chairman and chief executive officer of danimer, commented, “while 2023 was a challenging year for the company, we are greatly encouraged by the successes we had a.
Latest News
2024-05-01 11:06:50 - Zacks Investment Research
Will Danimer Scientific, Inc. (DNMR) Report Negative Q1 Earnings? What You Should Know
Danimer Scientific (DNMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2024-04-15 10:36:06 - Zacks Investment Research
Down -41.74% in 4 Weeks, Here's Why Danimer Scientific (DNMR) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for Danimer Scientific (DNMR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
2024-03-28 19:29:06 - Seeking Alpha
Danimer Scientific, Inc. (DNMR) Q4 2023 Earnings Call Transcript
2024-03-28 18:16:03 - Zacks Investment Research
Danimer Scientific, Inc. (DNMR) Reports Q4 Loss, Tops Revenue Estimates
Danimer Scientific, Inc. (DNMR) came out with a quarterly loss of $0.39 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.28 per share a year ago.
2023-11-14 19:03:04 - Seeking Alpha
Danimer Scientific, Inc. (DNMR) Q3 2023 Earnings Call Transcript
Danimer Scientific, Inc. (NYSE:DNMR ) Q3 2023 Earnings Call Transcript November 14, 2023 4:30 PM ET Company Participants James Palczynski - IR Steve Croskrey - Chairman and CEO Mike Hajost - CFO Conference Call Participants Jon Tanwanteng - CGS Securities Thomas Boyes - TD Cowen Charles Neivert - Piper Sandler Kevin Estok - Jefferies Operator Greetings. Welcome to the Danimer Scientific 2023 Third Quarter Earnings Call.
2023-11-14 18:47:11 - Zacks Investment Research
Danimer Scientific, Inc. (DNMR) Reports Q3 Loss, Misses Revenue Estimates
Danimer Scientific, Inc. (DNMR) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.30 per share a year ago.
2023-11-09 09:47:12 - Zacks Investment Research
Why Earnings Season Could Be Great for Danimer Scientific (DNMR)
Danimer Scientific (DNMR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
2023-11-07 12:17:00 - Business Wire
Danimer Scientific Announces Release Date for Third Quarter 2023 Results
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its third quarter 2023 financial results after the market closes on Tuesday November 14, 2023. A webcast and conference call will be held that same day at 4:30 p.m. Eastern Time to review the Company's third quarter results, discuss r.
2023-09-21 12:47:05 - Zacks Investment Research
Danimer Scientific (DNMR) Expands Partnership With CPChem
Danimer Scientific (DNMR) and CPChem collaborate again to explore numerous high-volume polymer applications utilizing Rinnovo materials.
2023-07-31 07:30:00 - Business Wire
Danimer Scientific Announces Release Date for Second Quarter 2023 Results
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading, next-generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its second quarter 2023 financial results after the market closes on Tuesday August 8, 2023. A webcast and conference call will be held that same day at 4:30 p.m. Eastern Time to review the Company's second quarter results, discuss re.